PuSH - Publication Server of Helmholtz Zentrum München

Kirsch, V.C.* ; Orgler, C.* ; Braig, S.* ; Jeremias, I. ; Auerbach, D.* ; Müller, R.* ; Vollmar, A.M.* ; Sieber, S.A.*

The cytotoxic natural product vioprolide A targets nucleolar protein 14 essential for ribosome biogenesis.

Angew. Chem.-Int. Edit. 59, 1595-1600 (2019)
Publ. Version/Full Text DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
Novel targets are needed for treatment of devastating diseases such as cancer. For decades, natural products have guided innovative therapies by addressing diverse pathways. Inspired by the potent cytotoxic bioactivity of myxobacterial vioprolides A-D, we performed in-depth studies on their mode of action. Based on its prominent potency against human acute lymphoblastic leukemia (ALL) cells, we conducted thermal proteome profiling (TPP) and deciphered the target proteins of the most active derivative vioprolide A (VioA) in Jurkat cells. Nucleolar protein 14 (NOP14), which is essential in ribosome biogenesis, was confirmed as a specific target of VioA by a suite of proteomic and biological follow-up experiments. Given its activity against ALL cells compared to healthy lymphocytes, VioA exhibits unique therapeutic potential for anticancer therapy through a novel mode of action.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Acute Lymphoblastic Leukemia ; Natural Products ; Quantitative Proteomics ; Ribosomess ; Target Identification; Computational Platform; Identification; Emg1
ISSN (print) / ISBN 1433-7851
e-ISSN 1521-3773
Quellenangaben Volume: 59, Issue: 4, Pages: 1595-1600 Article Number: , Supplement: ,
Publisher Wiley
Publishing Place Weinheim
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)